Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ. Hol L, et al. Among authors: van dekken h, van der togt ac, van vuuren aj, van leerdam me, van ballegooijen m. Gut. 2010 Jan;59(1):62-8. doi: 10.1136/gut.2009.177089. Gut. 2010. PMID: 19671542 Clinical Trial.
Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening.
van Roon AH, Goede SL, van Ballegooijen M, van Vuuren AJ, Looman CW, Biermann K, Reijerink JC, Mannetje H', van der Togt AC, Habbema JD, van Leerdam ME, Kuipers EJ. van Roon AH, et al. Among authors: van der togt ac, van vuuren aj, van leerdam me, van ballegooijen m. Gut. 2013 Mar;62(3):409-15. doi: 10.1136/gutjnl-2011-301583. Epub 2012 Mar 2. Gut. 2013. PMID: 22387523
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening.
Goede SL, van Roon AH, Reijerink JC, van Vuuren AJ, Lansdorp-Vogelaar I, Habbema JD, Kuipers EJ, van Leerdam ME, van Ballegooijen M. Goede SL, et al. Among authors: van roon ah, van vuuren aj, van leerdam me, van ballegooijen m. Gut. 2013 May;62(5):727-34. doi: 10.1136/gutjnl-2011-301917. Epub 2012 Apr 5. Gut. 2013. PMID: 22490518 Free PMC article.
A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening.
Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mundt MW, Spijker WJ, Bongers EJC, Kuipers EJ, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MCW. Grobbee EJ, et al. Among authors: van der vlugt m, van vuuren aj. Gut. 2017 Nov;66(11):1975-1982. doi: 10.1136/gutjnl-2016-311819. Epub 2016 Aug 9. Gut. 2017. PMID: 27507905 Clinical Trial.
Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model.
Meester RGS, van de Schootbrugge-Vandermeer HJ, Breekveldt ECH, de Jonge L, Toes-Zoutendijk E, Kooyker A, Nieboer D, Ramakers CR, Spaander MCW, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Nagtegaal ID, Dekker E, van Leerdam ME, Lansdorp-Vogelaar I; Dutch colorectal cancer screening working group. Meester RGS, et al. Among authors: van vuuren aj, van leerdam me, van kemenade fj, van de schootbrugge vandermeer hj. Gut. 2023 Jan;72(1):101-108. doi: 10.1136/gutjnl-2022-327188. Epub 2022 May 10. Gut. 2023. PMID: 35537811 Free PMC article.
Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis.
Toes-Zoutendijk E, de Jonge L, van Iersel CA, Spaander MCW, van Vuuren AJ, van Kemenade F, Ramakers CR, Dekker E, Nagetaal ID, van Leerdam ME, Lansdorp-Vogelaar I. Toes-Zoutendijk E, et al. Among authors: van vuuren aj. Gut. 2023 Jul;72(7):1319-1325. doi: 10.1136/gutjnl-2022-328559. Epub 2023 Apr 19. Gut. 2023. PMID: 37076272 Free PMC article.
84 results